Supplementary Material
Tusamitamab ravtansine maximum plasma concentrations by dose levelClick here for additional data file.Tusamitamab ravtansine area under the curve by dose levelClick here for additional data file.Reasons for screen failureClick here for additional data file.Representativeness of the patient populationClick here for additional data file.Intensity of treatmentClick here for additional data file.Plasma pharmacokinetics of tusamitamab ravtansine (cohort Q2W-LD)Click here for additional data file.Plasma pharmacokinetics of tusamitamab ravtansine (cohort Q3W)Click here for additional data file.